1-4 of 4
Hana Lee
Close
Sort by
Journal Articles

Novel IRF8 Splice Variants Are Validated As a New Prognostic Biomarker for Adverse Outcome in an Independent Population of Pediatric Patients with AML.

Derek L. Stirewalt, MD, Todd A. Alonzo, PhD, Era L. Pogosova-Agadjanyan, Robert B. Gerbing, M.A., Janet Franklin, MD, MPH, Hana Lee, Susana C. Raimondi, Betsy A. Hirsch, PhD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2550.
https://doi.org/10.1182/blood.V120.21.2550.2550
Published: 2012
Journal Articles

Expression Differences of Prognostic Biomarkers in Mononuclear Cells (MNCs) and Malignant Blasts of Acute Myeloid Leukemia (AML) Patients

Era L. Pogosova-Agadjanyan, Soheil Meshinchi, MD, Ph.D., Hana Lee, Brent L. Wood, MD, PhD, Derek L. Stirewalt, MD
Journal: Blood
Blood (2011) 118 (21): 1468.
https://doi.org/10.1182/blood.V118.21.1468.1468
Published: 2011
Journal Articles

Over-Expression of Novel IRF8 Splice Variants Is Associated with a Significant Decrease In Relapse-Free Survival In Adult AML Patients.

Era L. Pogosova-Agadjanyan, Kenneth J. Kopecky, PhD, Hana Lee, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Alan F. List, Soheil Meshinchi, MD, PhD, Vivian Oehler, MD, Stephen H. Petersdorf, MD, Cheryl L. Willman, MD, Frederick R. Appelbaum, MD, Jerald P. Radich, MD, Derek L. Stirewalt, MD
Journal: Blood
Blood (2010) 116 (21): 1679.
https://doi.org/10.1182/blood.V116.21.1679.1679
Published: 2010
Journal Articles

Methylation Regulates Expression of Novel Splice Variant and Wild Type Transcripts of IRF8.

Era L. Pogosova-Agadjanyan, Hana Lee, Crystal K. Cummings, Soheil Meshinchi, MD, PhD, Jerald P. Radich, MD, Derek L. Stirewalt, MD
Journal: Blood
Blood (2010) 116 (21): 3634.
https://doi.org/10.1182/blood.V116.21.3634.3634
Published: 2010